Elad Sharon: Designing clinical trials is all about tradeoffs

Elad Sharon, Clinical and Translational Director of Immunotherapy Toxicity Service at Dana-Farber Cancer Institute, shared on X/Twitter:

“Designing clinical trials is all about tradeoffs. A perfect trial is impossible, but the key is to have more information at the end of a trial than you had at the outset. Sounds like a simple idea, but often not followed.”

Source: Elad Sharon/X